There is a preponderance of receptors of incretin-based therapies (for example, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)-based receptor agonists) in central nervous system nuclei, including the hypothalamus and NAc, which regulate energy balance and reward processing 6,7 , underlying their therapeutic potential for obesity and type 2 diabetes 8,9,10
M., & Heymsfield, S
This article explains why this occurs, how common it may be, when to seek medical advice, and practical strategies to manage cold sensations safely whilst participating in a retatrutide clinical trial
Your Save Interactions List: A Step-by-Step Checklist While patients consider the concurrent use of Semaglutide and Adderall, a systematic approach to evaluating potential interactions is essential
How long does it take to see results with cagrilintide vs retatrutide